@prefix dcterms: .
@prefix this: .
@prefix sub: .
@prefix xsd: .
@prefix prov: .
@prefix np: .
@prefix orcid: .
@prefix nt: .
@prefix schema: .
@prefix nkg: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo .
}
sub:assertion {
schema:possibleTreatment sub:medtherapy .
sub:medtherapy prov:wasDerivedFrom sub:quote;
schema:drug ;
schema:targetPopulation sub:targetpop;
nkg:indicationType nkg:AdjunctiveTherapy .
sub:quote prov:value "Vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss";
prov:wasQuotedFrom .
}
sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0003-4665-7473 .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCC0CnI6yMUipkXh7RB8b/9rRnO8+qDR+pJVf//jGV0r2nd7JcvWFkhPN/eLja/pUw/+nvTE24rhKqK/jWxppJLoka+bk57wrYw43DrSbzQWoJc3ImWe3d08jSYt3mh3uOLWKciogBaonJUBohJsqhTmOULevIPONTZOMzeOJTWwQIDAQAB";
npx:hasSignature "SMoY3+Pw5txXR4ZS30apawCoROuFB2DscfnJCZWppVJj1jABDMESHkL56KkWUy5p5t4NfcWw1WKgRbv6KiQzlvtMt5962ewi0iVtCOqiHT/2yctQJiE5IFFkEfj8WifovUpOCFjSHKYBD+MucC7WkAmbuiGW60pmp6Dp/s6QRo8=";
npx:hasSignatureTarget this: .
this: dcterms:created "2021-04-04T21:36:27.877+02:00"^^xsd:dateTime;
dcterms:creator orcid:0000-0003-4665-7473;
nt:wasCreatedFromProvenanceTemplate ;
nt:wasCreatedFromPubinfoTemplate ;
nt:wasCreatedFromTemplate .
}